Safety Study of Elvucitabine in HIV-1 Subjects
NCT00405249
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
elvucitabine
Sponsor
Thomas Jefferson University